XML 23 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Operating activities      
Net earnings $ 10,823 $ 7,073 $ 5,868
Noncash items:      
Depreciation and amortization 2,245 2,055 1,693
Deferred income taxes (965) 81 (73)
Share-based compensation 597 485 406
Other, net 217 (82) (235)
Net change in other operating items, net of effects from acquisitions and changes in AARP balances:      
Accounts receivable (1,062) (1,357) (591)
Other assets (630) (1,601) (1,430)
Medical costs payable 1,284 1,849 2,585
Accounts payable and other liabilities 930 1,494 1,280
Unearned revenues 157 (202) 237
Cash flows from operating activities 13,596 9,795 9,740
Investing activities      
Purchases of investments (14,588) (17,547) (9,939)
Sales of investments 4,623 7,339 6,054
Maturities of investments 5,646 4,281 3,354
Cash paid for acquisitions, net of cash assumed (2,131) (1,760) (16,164)
Purchases of property, equipment and capitalized software (2,023) (1,705) (1,556)
Other, net (126) 37 (144)
Cash flows used for investing activities (8,599) (9,355) (18,395)
Financing activities      
Common share repurchases (1,500) (1,280) (1,200)
Cash dividends paid (2,773) (2,261) (1,786)
Proceeds from common stock issuances 688 429 402
Repayments of long-term debt (4,398) (2,596) (1,041)
(Repayments of) proceeds from commercial paper, net (3,508) (382) 3,666
Proceeds from issuance of long-term debt 5,291 3,968 11,982
Customer funds administered 3,172 1,692 768
Other, net (413) (581) (552)
Cash flows (used for) from financing activities (3,441) (1,011) 12,239
Effect of exchange rate changes on cash and cash equivalents (5) 78 (156)
Increase (decrease) in cash and cash equivalents 1,551 (493) 3,428
Cash and cash equivalents, beginning of period 10,430 10,923 7,495
Cash and cash equivalents, end of period 11,981 10,430 10,923
Supplemental cash flow disclosures      
Cash paid for interest 1,133 1,055 639
Cash paid for income taxes 4,004 4,726 4,401
Supplemental schedule of non-cash investing activities      
Common stock issued for acquisitions $ 2,164 $ 0 $ 0